Clinician Concepts of Cure in Adult Relapsed and Refractory Philadelphia-Negative B Cell Precursor Acute Lymphoblastic Leukemia: A Delphi Study

[1]  C. Buske,et al.  Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  D. Metz,et al.  Consensus on biomarkers for neuroendocrine tumour disease. , 2015, The Lancet. Oncology.

[3]  D. Hoelzer.  Personalized medicine in adult acute lymphoblastic leukemia , 2015, Haematologica.

[4]  Alberto Orfao,et al.  Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies. , 2015, Blood.

[5]  W. Greiner,et al.  Which Metrics Are Appropriate to Describe the Value of New Cancer Therapies? , 2015, BioMed research international.

[6]  R. Bassan,et al.  Minimal Residual Disease Monitoring in Adult ALL to Determine Therapy , 2015, Current Hematologic Malignancy Reports.

[7]  J. Bourhis,et al.  Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia. , 2015, Blood.

[8]  N. Abousamra,et al.  Clinical significance of minimal residual disease in young adults with standard-risk/Ph-negative precursor B-acute lymphoblastic leukemia: results of prospective study , 2014, Medical Oncology.

[9]  E. Shpall,et al.  Outcomes of adults with acute lymphoblastic leukemia relapsing after allogeneic hematopoietic stem cell transplantation. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[10]  J. Rowe,et al.  The myth of the second remission of acute leukemia in the adult. , 2013, Blood.

[11]  K. Kreuzer,et al.  Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation. , 2012, Blood.

[12]  八木 真衣,et al.  Prognostic factors in adult acute lymphoblastic leukemia , 2012 .

[13]  J. Brandwein.  Treatment of acute lymphoblastic leukemia in adolescents and young adults. , 2011, Current oncology reports.

[14]  F. Huguet.  [Adult acute lymphoblastic leukemia]. , 2011, La Revue du praticien.

[15]  D. Hoelzer,et al.  Modern therapy of acute lymphoblastic leukemia. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  H. Kantarjian,et al.  Defining the course and prognosis of adults with acute lymphocytic leukemia in first salvage after induction failure or short first remission duration , 2010, Cancer.

[17]  M. Tormo,et al.  Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group , 2010, Haematologica.

[18]  C. Pui,et al.  Adult acute lymphoblastic leukemia , 2010, Cancer.

[19]  H. Dombret,et al.  Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  H. Dombret,et al.  Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial , 2007, Leukemia.

[21]  Chia-Chien Hsu,et al.  The Delphi Technique: Making Sense of Consensus , 2007 .

[22]  S. Thangaratinam,et al.  The Delphi technique , 2005 .

[23]  C. Bloomfield,et al.  Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  X. Thomas,et al.  Prognostic Factors in Adult Acute Lymphoblastic Leukemia , 2003, Hematology.

[25]  T. Lipp,et al.  Treatment of Adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL). , 2000, Hematology/oncology clinics of North America.

[26]  Terry L. Smith,et al.  Primary refractory and relapsed adult acute lymphoblastic leukemia , 1999, Cancer.